Healthcare Market News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 437,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "dd64dbb9-4a12-438e-ac12-bd2f85590236",
"title": "Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results",
"description": "PR NewswireALPHARETTA, Ga., July 24, 2025\n\n\n\nALPHARETTA, Ga., July 24, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call",
"keywords": "GuruFocus, Article, News, PRNewswire, NYSE:AVNS",
"snippet": "ALPHARETTA, Ga., July 24, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business high...",
"url": "https://www.gurufocus.com/news/3002442/avanos-medical-inc-to-webcast-conference-call-discussing-second-quarter-2025-financial-results",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T16:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AVNS",
"name": "Avanos Medical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 163.39743,
"sentiment_score": 0.23614,
"highlights": [
{
"highlight": "., July 24, 2025 /PRNewswire/ -- <em>Ava[+318 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A simultaneous webcast of the call and t[+257 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Avanos</em> <em>Medical</em>, [+237 characters]",
"sentiment": 0.8625,
"highlighted_in": "main_text"
},
{
"highlight": "For more information, visit www.avanos.c[+357 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Avanos</em> <em>Medical</em>, <em>Inc</em>. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "b74188fd-b7e8-4652-80da-0c22ee5d2049",
"title": "Insmed to Host Second-Quarter 2025 Financial Results Conference Call on Thursday, August 7, 2025",
"description": "PR NewswireBRIDGEWATER, N.J., July 24, 2025\n\n\n\nBRIDGEWATER, N.J., July 24, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biop",
"keywords": "GuruFocus, Article, News, PRNewswire, NAS:INSM",
"snippet": "BRIDGEWATER, N.J., July 24, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- ...",
"url": "https://www.gurufocus.com/news/3001155/insmed-to-host-secondquarter-2025-financial-results-conference-call-on-thursday-august-7-2025",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T13:00:21.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "INSM",
"name": "Insmed Incorporated",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 79.38928,
"sentiment_score": 0.04095,
"highlights": [
{
"highlight": "., July 24, 2025 /PRNewswire/ -- <em>Ins[+335 characters]",
"sentiment": -0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "About Insmed\n\n<em>Insmed</em> <em>Incorp[+177 characters]",
"sentiment": -0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Relations\n\n(646) 812-4030\n\n[email protec[+327 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Incorporated</em>",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "a6b40180-5d72-4ac9-af19-dd9cbf73eee9",
"title": "Lilly confirms date and conference call for second-quarter 2025 financial results announcement",
"description": "PR NewswireINDIANAPOLIS, July 24, 2025\n\n\n\nINDIANAPOLIS, July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2025",
"keywords": "GuruFocus, Article, News, PRNewswire, NYSE:LLY",
"snippet": "INDIANAPOLIS, July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2025 financial results on August 7, 2025. Lilly w...",
"url": "https://www.gurufocus.com/news/3002443/lilly-confirms-date-and-conference-call-for-secondquarter-2025-financial-results-announcement",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T16:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "LLY.DE",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 48.066673,
"sentiment_score": 0.1591,
"highlights": [
{
"highlight": "INDIANAPOLIS, July 24, 2025 /PRNewswire/[+339 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "View original content to download multim[+221 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 66.67363,
"sentiment_score": 0.1591,
"highlights": [
{
"highlight": "INDIANAPOLIS, July 24, 2025 /PRNewswire/[+357 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "View original content to download multim[+221 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.MX",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 48.06534,
"sentiment_score": 0.1591,
"highlights": [
{
"highlight": "INDIANAPOLIS, July 24, 2025 /PRNewswire/[+339 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "View original content to download multim[+221 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "a92dcf88-9cda-41f5-8aca-93d26c532b71",
"title": "Lilly confirms date and conference call for second-quarter 2025 financial results announcement | LLY Stock News",
"description": "Eli Lilly (LLY) will announce its second-quarter 2025 financial results on August 7, 2025. A conference call will be held at 8:30 a.m. Eastern time to d",
"keywords": "GuruFocus, Article, News, GuruFocus News, LLY",
"snippet": "Eli Lilly (LLY, Financial) will announce its second-quarter 2025 financial results on August 7, 2025.\n\nA conference call will be held at 8:30 a.m. Eastern time ...",
"url": "https://www.gurufocus.com/news/3002321/lilly-confirms-date-and-conference-call-for-secondquarter-2025-financial-results-announcement-lly-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007E3.png?20",
"language": "en",
"published_at": "2025-07-24T15:16:23.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "LLY.DE",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.10611,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "<em>Eli</em> <em>Lilly</em> <em>and</em>[+288 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.10524,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "<em>Eli</em> <em>Lilly</em> <em>and</em>[+288 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.MX",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.10502,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "<em>Eli</em> <em>Lilly</em> <em>and</em>[+288 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "362dc718-ff12-44cf-af8c-8bddabd75470",
"title": "Eli Lilly and Co (LLY) Completes Tender Offer for Verve Therapeutics | LLY stock news",
"description": "Summary On July 24, 2025, Eli Lilly and Co (LLY) announced the successful completion of its tender offer to acquire all outstanding shares of Verve Therapeutics",
"keywords": "GuruFocus, Article, News, GuruFocus News, LLY",
"snippet": "Summary\n\nOn July 24, 2025, Eli Lilly and Co (LLY, Financial) announced the successful completion of its tender offer to acquire all outstanding shares of Verve ...",
"url": "https://www.gurufocus.com/news/3001851/eli-lilly-and-co-lly-completes-tender-offer-for-verve-therapeutics-lly-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T14:05:50.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "VERV",
"name": "Verve Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 82.174805,
"sentiment_score": 0.561125,
"highlights": [
{
"highlight": "Summary\n\nOn July 24, 2025, Eli Lilly and[+330 characters]",
"sentiment": 0.9413,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+303 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nIn [+231 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Eli Lilly and Co (LLY) Completes Tender Offer for <em>Verve</em> <em>Therapeutics</em> | LLY stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "daa665a9-bc77-40f3-ad8d-9435e632fa38",
"title": "Lilly and Verve announce expiration of Verve tender offer | LLY Stock News",
"description": "Eli Lilly (LLY) concludes tender offer for Verve Therapeutics (VERV) shares. Approximately 55.7% of Verve's shares were tendered by the expiration time.",
"keywords": "GuruFocus, Article, News, GuruFocus News, LLY",
"snippet": "Eli Lilly (LLY, Financial) concludes tender offer for Verve Therapeutics (VERV) shares.\n\nApproximately 55.7% of Verve's shares were tendered by the expiration t...",
"url": "https://www.gurufocus.com/news/3001180/lilly-and-verve-announce-expiration-of-verve-tender-offer-lly-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007E3.png?20",
"language": "en",
"published_at": "2025-07-24T13:00:39.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "LLY",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 43.327885,
"sentiment_score": 0.875,
"highlights": [
{
"highlight": "<em>Eli</em> <em>Lilly</em> <em>and</em>[+191 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LILY34.SA",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 43.327972,
"sentiment_score": 0.875,
"highlights": [
{
"highlight": "<em>Eli</em> <em>Lilly</em> <em>and</em>[+191 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.BA",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 43.327553,
"sentiment_score": 0.875,
"highlights": [
{
"highlight": "<em>Eli</em> <em>Lilly</em> <em>and</em>[+191 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "VERV",
"name": "Verve Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 66.01296,
"sentiment_score": 0.7372,
"highlights": [
{
"highlight": "Eli Lilly (LLY, Financial) concludes ten[+295 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>VERV</em>) have announced the succe[+107 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.DE",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 43.328133,
"sentiment_score": 0.875,
"highlights": [
{
"highlight": "<em>Eli</em> <em>Lilly</em> <em>and</em>[+191 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.MX",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 43.326958,
"sentiment_score": 0.875,
"highlights": [
{
"highlight": "<em>Eli</em> <em>Lilly</em> <em>and</em>[+191 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "a0e13608-3106-42cd-8b67-cabcc203e783",
"title": "VERSANT Board of Directors for Future Independent Media Company Announced",
"description": "Comcast Corporation (Nasdaq: CMCSA) today announced the expected members of the first Board of Directors of VERSANT Media Group, Inc., Comcast's planned spin-o",
"keywords": "GuruFocus, Article, News, Business Wire, NAS:CMCSA",
"snippet": "Comcast Corporation (Nasdaq: CMCSA) today announced the expected members of the first Board of Directors of VERSANT Media Group, Inc., Comcast’s planned spin-...",
"url": "https://www.gurufocus.com/news/3002433/versant-board-of-directors-for-future-independent-media-company-announced",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T16:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "JNJ",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.16938,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Prior to joining Starbucks, he worked at[+290 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "9be90e73-fee0-4290-b57a-8b484a93459e",
"title": "Comcast spinoff Versant announces board of directors. Here's the slate",
"description": "Comcast's spinoff of it's cable networks and some digital assets is expected to be completed by the end of this year.",
"keywords": "Media, Breaking News: Business, Comcast Corp, Entertainment, Business, Yum! Brands Inc, Walt Disney Co, Starbucks Corp, Johnson & Johnson, Campbell Soup Co, Bank of New York Mellon Corp, MetLife Inc, McCormick & Company Inc, Royal Caribbean Cruises Ltd, business news",
"snippet": "Versant signage on the floor at the New York Stock Exchange (NYSE) in New York, US, on Monday, July 21, 2025.\n\nComcast on Thursday announced the expected board ...",
"url": "https://www.cnbc.com/2025/07/24/comcast-spinoff-versant-board-of-directors.html",
"image_url": "https://image.cnbcfm.com/api/v1/image/108175133-1753196329775-gettyimages-2225443118-US_STOCKS.jpeg?v=1753196353&w=1920&h=1080",
"language": "en",
"published_at": "2025-07-24T14:17:25.000000Z",
"source": "cnbc.com",
"relevance_score": null,
"entities": [
{
"symbol": "BK",
"name": "The Bank of New York Mellon Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 24.519896,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Gerald Hassell\n\nGerald Hassell is the fo[+256 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "YUM",
"name": "Yum! Brands, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 18.485203,
"sentiment_score": -0.4003,
"highlights": [
{
"highlight": "He is a longtime board member of Comcast[+282 characters]",
"sentiment": -0.4003,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DIS",
"name": "The Walt Disney Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 34.077896,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Rebecca Campbell\n\nRebecca Campbell is th[+282 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "RCL",
"name": "Royal Caribbean Group",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 17.055279,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Montiel has served on the board of direc[+184 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CPB",
"name": "Campbell Soup Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 35.822506,
"sentiment_score": 0.8225,
"highlights": [
{
"highlight": "Prior to Starbucks, he worked at Johnson[+267 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MET",
"name": "MetLife, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 13.570464,
"sentiment_score": 0,
"highlights": [
{
"highlight": "He is also a former director of Comcast [+236 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "JNJ",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 25.40264,
"sentiment_score": 0.8225,
"highlights": [
{
"highlight": "Prior to Starbucks, he worked at <em>Joh[+258 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "WDP.DE",
"name": "The Walt Disney Company",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Communication Services",
"match_score": 29.595753,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Rebecca Campbell\n\nRebecca Campbell is th[+282 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CSC.DE",
"name": "Campbell Soup Company",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 31.339972,
"sentiment_score": 0.8225,
"highlights": [
{
"highlight": "Prior to Starbucks, he worked at Johnson[+267 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DIS.MX",
"name": "The Walt Disney Company",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Communication Services",
"match_score": 29.594707,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Rebecca Campbell\n\nRebecca Campbell is th[+282 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "b5ed74dc-944f-4a0a-9606-01c172af1b78",
"title": "Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results | AVNS Stock News",
"description": "Avanos Medical Inc. (AVNS) has scheduled its Q2 2025 earnings call for August 5, 2025, at 9 a.m. ET. The financial results will be released prior to mar",
"keywords": "GuruFocus, Article, News, GuruFocus News, AVNS",
"snippet": "Avanos Medical Inc. (AVNS, Financial) has scheduled its Q2 2025 earnings call for August 5, 2025, at 9 a.m. ET.\n\nThe financial results will be released prior to...",
"url": "https://www.gurufocus.com/news/3002400/avanos-medical-inc-to-webcast-conference-call-discussing-second-quarter-2025-financial-results-avns-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000AR8X.png?20",
"language": "en",
"published_at": "2025-07-24T15:45:41.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AVNS",
"name": "Avanos Medical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 120.036705,
"sentiment_score": 0.285167,
"highlights": [
{
"highlight": "<em>Avanos</em> <em>Medical</em> <em>Inc[+318 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Avanos</em> <em>Medical</em>, headqu[+238 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Avanos</em> <em>Medical</em>, <em>Inc</em>. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results | AVNS Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "33da885a-b7aa-4445-8d46-0e8097e62a9f",
"title": "Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025",
"description": "SEATTLE and VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. ( ACHV), a late-stage specialty pharmaceutical company",
"keywords": "GuruFocus, Article, News, Marketwired, ACHV",
"snippet": "SEATTLE and VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. ( ACHV), a late-stage specialty pharmaceutical company fo...",
"url": "https://www.gurufocus.com/news/3001604/achieve-life-sciences-to-announce-second-quarter-financial-results-and-host-conference-call-and-webcast-on-august-7-2025",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T14:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ACHV",
"name": "Achieve Life Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 71.90315,
"sentiment_score": 0.218333,
"highlights": [
{
"highlight": "SEATTLE and VANCOUVER, British Columbia,[+352 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "About Achieve\n\n<em>Achieve</em> <em>Life[+219 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Achieve</em> <em>Life</em> <em>Sciences</em> to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "59e13b1a-0241-45b7-943c-45d6f6d5dc76",
"title": "HCSG: Benchmark Raises Price Target for Healthcare Services Group | HCSG Stock News",
"description": "In a recent update, Benchmark analyst Bill Sutherland has maintained a",
"keywords": "GuruFocus, Article, News, GuruFocus News, HCSG",
"snippet": "In a recent update, Benchmark analyst Bill Sutherland has maintained a \"Buy\" rating for Healthcare Services Group (HCSG, Financial), reiterating confidence in t...",
"url": "https://www.gurufocus.com/news/3002388/hcsg-benchmark-raises-price-target-for-healthcare-services-group-hcsg-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000B8N.png?20",
"language": "en",
"published_at": "2025-07-24T15:33:24.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HCSG",
"name": "Healthcare Services Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 73.42235,
"sentiment_score": 0.303025,
"highlights": [
{
"highlight": "In a recent update, Benchmark analyst Bi[+248 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Healthcare</em> <em>Services</em> Gr[+315 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "As of the latest data, <em>Healthcare</e[+185 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+313 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+303 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+274 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+85 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "HCSG: Benchmark Raises Price Target for <em>Healthcare</em> <em>Services</em> Group | HCSG Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "eb865bc0-ed2d-4afb-a7ef-9d02ad337102",
"title": "Healthcare Services Group (HCSG) Price Target Raised by Baird Analyst | HCSG Stock News",
"description": "On July 24, 2025, analyst Andrew Wittmann from Baird announced a revised price target for Healthcare Services Group (HCSG). The new price target has been set to",
"keywords": "GuruFocus, Article, News, GuruFocus News, HCSG",
"snippet": "On July 24, 2025, analyst Andrew Wittmann from Baird announced a revised price target for Healthcare Services Group (HCSG, Financial). The new price target has ...",
"url": "https://www.gurufocus.com/news/3001486/healthcare-services-group-hcsg-price-target-raised-by-baird-analyst-hcsg-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000B8N.png?20",
"language": "en",
"published_at": "2025-07-24T13:35:43.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HCSG",
"name": "Healthcare Services Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 67.48545,
"sentiment_score": 0.198425,
"highlights": [
{
"highlight": "On July 24, 2025, analyst Andrew Wittman[+270 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Healthcare</em> <em>Services</em> Gr[+154 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Investors and market observers will be k[+218 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+313 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+303 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+274 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+85 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Healthcare</em> <em>Services</em> Group (HCSG) Price Target Raised by Baird Analyst | HCSG Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "a290d886-a400-4f21-ab9b-86a9e72e3109",
"title": "HCSG Stock Price Target Raised by Baird Following Q2 Results | HCSG Stock News",
"description": "Baird has increased its price target for Healthcare Services Group (HCSG) from $13 to $15 while maintaining a Neutral stance on the stock. This adjustment follo",
"keywords": "GuruFocus, Article, News, GuruFocus News, HCSG",
"snippet": "Baird has increased its price target for Healthcare Services Group (HCSG, Financial) from $13 to $15 while maintaining a Neutral stance on the stock. This adjus...",
"url": "https://www.gurufocus.com/news/3001245/hcsg-stock-price-target-raised-by-baird-following-q2-results-hcsg-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000B8N.png?20",
"language": "en",
"published_at": "2025-07-24T13:16:50.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HCSG",
"name": "Healthcare Services Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 39.665752,
"sentiment_score": 0.375217,
"highlights": [
{
"highlight": "Baird has increased its price target for[+216 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+313 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+303 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+274 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+336 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Healthcare</em> <em[+337 characters]",
"sentiment": 0.936,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "4b35d91f-9f78-4759-9ac6-3b4e83dfccb8",
"title": "Healthcare Services Group Inc (HCSG) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges",
"description": "Revenue: $458.5 million, an increase of 7.6% over the prior year.Environmental Services Revenue: $205.8 million.Dietary Services Revenue: $252.7 million.Cost o",
"keywords": "GuruFocus, Article, News, GuruFocus News, HCSG",
"snippet": "Release Date: July 23, 2025\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nPositive Points\n\nHealthcare S...",
"url": "https://www.gurufocus.com/news/3000134/healthcare-services-group-inc-hcsg-q2-2025-earnings-call-highlights-revenue-growth-amidst-challenges",
"image_url": "https://static.gurufocus.com/logos/0C00000B8N.png?5",
"language": "en",
"published_at": "2025-07-24T07:06:20.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HCSG",
"name": "Healthcare Services Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 111.022766,
"sentiment_score": 0.6882,
"highlights": [
{
"highlight": "Positive Points\n\n<em>Healthcare</em> <em[+337 characters]",
"sentiment": 0.936,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Healthcare</em> <em>Services</em> <em>Group</em> <em>Inc</em> (HCSG) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges",
"sentiment": 0.4404,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "b7322212-b594-4c7f-b43f-524a85e8e6bd",
"title": "AnaptysBio (ANAB) Price Target Raised by JP Morgan | ANAB Stock News",
"description": "On July 24, 2025, AnaptysBio (ANAB) received a positive update from JP Morgan. The financial services firm has maintained its \"Overweight\" rating on the stock.",
"keywords": "GuruFocus, Article, News, GuruFocus News, ANAB",
"snippet": "On July 24, 2025, AnaptysBio (ANAB, Financial) received a positive update from JP Morgan. The financial services firm has maintained its \"Overweight\" rating on ...",
"url": "https://www.gurufocus.com/news/3002387/anaptysbio-anab-price-target-raised-by-jp-morgan-anab-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000AZT9.png?20",
"language": "en",
"published_at": "2025-07-24T15:33:11.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ANAB",
"name": "AnaptysBio, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 69.02768,
"sentiment_score": 0.356083,
"highlights": [
{
"highlight": "On July 24, 2025, <em>AnaptysBio</em> (A[+292 characters]",
"sentiment": 0.8993,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AnaptysBio</em> (ANAB, Financial) co[+314 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+253 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+241 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+52 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AnaptysBio</em> (ANAB) Price Target Raised by JP Morgan | ANAB Stock News",
"sentiment": 0.368,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "93beb5a0-a5cb-4228-9787-b3e5f7d4cbf3",
"title": "JP Morgan Raises Price Target for ACADIA Pharmaceuticals (ACAD) | ACAD Stock News",
"description": "JP Morgan analyst Tessa Romero has updated her stance on ACADIA Pharmaceuticals (ACAD), maintaining an",
"keywords": "GuruFocus, Article, News, GuruFocus News, ACAD",
"snippet": "JP Morgan analyst Tessa Romero has updated her stance on ACADIA Pharmaceuticals (ACAD, Financial), maintaining an \"Overweight\" rating while raising the stock's ...",
"url": "https://www.gurufocus.com/news/3002383/jp-morgan-raises-price-target-for-acadia-pharmaceuticals-acad-acad-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000973.png?20",
"language": "en",
"published_at": "2025-07-24T15:32:28.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ACAD",
"name": "ACADIA Pharmaceuticals Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 91.42587,
"sentiment_score": 0.284588,
"highlights": [
{
"highlight": "JP Morgan analyst Tessa Romero has updat[+253 characters]",
"sentiment": 0.5904,
"highlighted_in": "main_text"
},
{
"highlight": "The adjusted price target and maintained[+224 characters]",
"sentiment": 0.7739,
"highlighted_in": "main_text"
},
{
"highlight": "The \"Overweight\" rating indicates that t[+208 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+303 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+295 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+262 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+73 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "JP Morgan Raises Price Target for <em>ACADIA</em> <em>Pharmaceuticals</em> (ACAD) | ACAD Stock News",
"sentiment": 0.368,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "f79b9210-6c25-4467-9b54-f3697f7eb356",
"title": "Sarepta (SRPT): Jefferies Adjusts Price Target Amid Elevidys Sales Update | SRPT Stock News",
"description": "Jefferies has revised its price target for Sarepta (SRPT), reducing it from $40 to $35, while maintaining a Buy rating on the stock. The adjustment follows a re",
"keywords": "GuruFocus, Article, News, GuruFocus News, SRPT",
"snippet": "Jefferies has revised its price target for Sarepta (SRPT, Financial), reducing it from $40 to $35, while maintaining a Buy rating on the stock. The adjustment f...",
"url": "https://www.gurufocus.com/news/3002371/sarepta-srpt-jefferies-adjusts-price-target-amid-elevidys-sales-update-srpt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AIQ.png?20",
"language": "en",
"published_at": "2025-07-24T15:30:48.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SRPT",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 65.66194,
"sentiment_score": 0.47625,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+264 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Sarepta</em> <em>Th[+270 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> <[+253 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "2b98647b-e99e-403e-bae5-349fa5f04eee",
"title": "Wells Fargo Updates Price Target for Sarepta Therapeutics (SRPT) | SRPT Stock News",
"description": "On July 24, 2025, Wells Fargo analyst Yanan Zhu updated the price target for Sarepta Therapeutics (SRPT). The analyst maintained an \"Overweight\" rating on the s",
"keywords": "GuruFocus, Article, News, GuruFocus News, SRPT",
"snippet": "On July 24, 2025, Wells Fargo analyst Yanan Zhu updated the price target for Sarepta Therapeutics (SRPT, Financial). The analyst maintained an \"Overweight\" rati...",
"url": "https://www.gurufocus.com/news/3002237/wells-fargo-updates-price-target-for-sarepta-therapeutics-srpt-srpt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AIQ.png?20",
"language": "en",
"published_at": "2025-07-24T15:02:07.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SRPT",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 92.550735,
"sentiment_score": 0.131771,
"highlights": [
{
"highlight": "On July 24, 2025, Wells Fargo analyst Ya[+296 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> ([+209 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+263 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+71 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wells Fargo Updates Price Target for <em>Sarepta</em> <em>Therapeutics</em> (SRPT) | SRPT Stock News",
"sentiment": 0.25,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "881686f3-3d9b-48d2-95de-ad46ac3185fc",
"title": "Sarepta (SRPT) Gene Therapy Unrelated to Patient Death in Brazil | SRPT Stock News",
"description": "Roche has announced that the death of a Duchenne muscular dystrophy patient in Brazil, who had received Sarepta's (SRPT) gene therapy Elevidys, is not linked to",
"keywords": "GuruFocus, Article, News, GuruFocus News, SRPT",
"snippet": "Roche has announced that the death of a Duchenne muscular dystrophy patient in Brazil, who had received Sarepta's (SRPT, Financial) gene therapy Elevidys, is no...",
"url": "https://www.gurufocus.com/news/3002045/sarepta-srpt-gene-therapy-unrelated-to-patient-death-in-brazil-srpt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AIQ.png?20",
"language": "en",
"published_at": "2025-07-24T14:32:04.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SRPT",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 65.68825,
"sentiment_score": 0.47625,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+261 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Sarepta</em> <em>Th[+270 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> <[+253 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "39a4e50d-7600-4500-9715-43988cc1edf6",
"title": "Sarepta (SRPT) Faces Setback with Paused Dosing of Gene Therapy | SRPT Stock News",
"description": "Roche has released an important update on the Elevidys gene therapy, developed in collaboration with Sarepta (SRPT), targeting Duchenne muscular dystrophy in no",
"keywords": "GuruFocus, Article, News, GuruFocus News, SRPT",
"snippet": "Roche has released an important update on the Elevidys gene therapy, developed in collaboration with Sarepta (SRPT, Financial), targeting Duchenne muscular dyst...",
"url": "https://www.gurufocus.com/news/3001962/sarepta-srpt-faces-setback-with-paused-dosing-of-gene-therapy-srpt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AIQ.png?20",
"language": "en",
"published_at": "2025-07-24T14:20:18.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SRPT",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 64.67726,
"sentiment_score": 0.47625,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+261 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Sarepta</em> <em>Th[+270 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> <[+253 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "6f477e6b-8615-47c2-ba4a-97f710197343",
"title": "Sarepta (SRPT) Faces Potential EU Rejection of Elevidys | SRPT Stock News",
"description": "H.C. Wainwright analyst Mitchell Kapoor maintains a Sell rating for Sarepta (SRPT), setting a neutral price projection. Sarepta's stock declined by 2% on Wednes",
"keywords": "GuruFocus, Article, News, GuruFocus News, SRPT",
"snippet": "H.C. Wainwright analyst Mitchell Kapoor maintains a Sell rating for Sarepta (SRPT, Financial), setting a neutral price projection. Sarepta's stock declined by 2...",
"url": "https://www.gurufocus.com/news/3000920/sarepta-srpt-faces-potential-eu-rejection-of-elevidys-srpt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AIQ.png?20",
"language": "en",
"published_at": "2025-07-24T12:36:29.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0L35.L",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 64.682304,
"sentiment_score": 0.47625,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+261 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Sarepta</em> <em>Th[+270 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> <[+253 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SRPT",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 64.66939,
"sentiment_score": 0.47625,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+261 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Sarepta</em> <em>Th[+270 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> <[+253 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "1db4d059-3ef7-48c8-9e88-23d600702c52",
"title": "Sarepta (SRPT) Targets Revised, Positive Outlook on Resuming Shipments | SRPT Stock News",
"description": "Wells Fargo has adjusted its price target for Sarepta (SRPT), reducing it from $65 to $48, while maintaining an Overweight rating on the company's stock. Recent",
"keywords": "GuruFocus, Article, News, GuruFocus News, SRPT",
"snippet": "Wells Fargo has adjusted its price target for Sarepta (SRPT, Financial), reducing it from $65 to $48, while maintaining an Overweight rating on the company's st...",
"url": "https://www.gurufocus.com/news/3000778/sarepta-srpt-targets-revised-positive-outlook-on-resuming-shipments-srpt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AIQ.png?20",
"language": "en",
"published_at": "2025-07-24T12:19:15.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SRPT",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 64.70332,
"sentiment_score": 0.47625,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+261 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Sarepta</em> <em>Th[+270 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> <[+253 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0L35.L",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 64.682304,
"sentiment_score": 0.47625,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+261 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Sarepta</em> <em>Th[+270 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> <[+253 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "5f7d7ecc-c1d0-4ca9-868c-ef446199b382",
"title": "West Pharmaceutical (WST) Surges Nearly 24% in Market Rally | WST Stock News",
"description": "West Pharmaceutical (WST) experienced a significant rise in its stock price, climbing 23.9% to reach $281.75. This increase equates to a gain of $54.44. The sur",
"keywords": "GuruFocus, Article, News, GuruFocus News, WST",
"snippet": "West Pharmaceutical (WST, Financial) experienced a significant rise in its stock price, climbing 23.9% to reach $281.75. This increase equates to a gain of $54....",
"url": "https://www.gurufocus.com/news/3002339/west-pharmaceutical-wst-surges-nearly-24-in-market-rally-wst-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000009N9.png?20",
"language": "en",
"published_at": "2025-07-24T15:17:33.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "WST",
"name": "West Pharmaceutical Services, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 55.880016,
"sentiment_score": 0.085225,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+322 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+323 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+277 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+87 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "f5b51ebb-74f0-48ad-8216-c69e76ad5993",
"title": "Collegium Pharmaceutical Inc (COLL) Announces Q2 2025 Financial Results Release Date | COLL stock news",
"description": "Summary Collegium Pharmaceutical Inc (COLL), a leading biopharmaceutical company, announced that it will release its second quarter 2025 financial results on Au",
"keywords": "GuruFocus, Article, News, GuruFocus News, COLL",
"snippet": "Summary\n\nCollegium Pharmaceutical Inc (COLL, Financial), a leading biopharmaceutical company, announced that it will release its second quarter 2025 financial r...",
"url": "https://www.gurufocus.com/news/3001857/collegium-pharmaceutical-inc-coll-announces-q2-2025-financial-results-release-date-coll-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T14:08:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "COLL",
"name": "Collegium Pharmaceutical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 129.1785,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Summary\n\n<em>Collegium</em> <em>Pharmace[+317 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: When will <em>Collegium</em> <em[+196 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A: Investors can dial (877) 407-8037 (U.[+325 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Collegium</em> <em>Pharmaceutical</em> <em>Inc</em> (COLL) Announces Q2 2025 Financial Results Release Date | COLL stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "cd359dc9-99a8-4b2d-bd54-5a6eb7358a54",
"title": "West Pharmaceutical Services Inc (WST) Q2 2025 Earnings: EPS of $1.82 Beats Estimate, Revenue Reaches $766.5 Million Surpassing Expectations",
"description": "Revenue: $766.5 million, surpassing the estimated $726.45 million, marking a 9.2% increase year-over-year.Diluted EPS: Achieved $1.82, exceeding the estimated",
"keywords": "GuruFocus, Article, News, GuruFocus News, WST",
"snippet": "West Pharmaceutical Services Inc (WST, Financial) released its 8-K filing on July 24, 2025, announcing its financial results for the second quarter of 2025. The...",
"url": "https://www.gurufocus.com/news/3000864/west-pharmaceutical-services-inc-wst-q2-2025-earnings-eps-of-182-beats-estimate-revenue-reaches-7665-million-surpassing-expectations",
"image_url": "https://static.gurufocus.com/logos/0C000009N9.png?5",
"language": "en",
"published_at": "2025-07-24T12:31:06.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "WST",
"name": "West Pharmaceutical Services, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 124.95098,
"sentiment_score": 0.370033,
"highlights": [
{
"highlight": "<em>West</em> <em>Pharmaceutical</em> <e[+281 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview\n\n<em>West</em> <em>Phar[+285 characters]",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Achievements\n\n<em>West</em> <e[+301 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Metric Q2 2025 Q2 2024 Net Sales $766.5 [+281 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings releas[+103 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>West</em> <em>Pharmaceutical</em> <em>Services</em> <em>Inc</em> (WST) Q2 2025 Earnings: EPS of $1.82 Beats Estimate, Revenue Reaches $766.5 Million Surpassing Expectations",
"sentiment": 0.0516,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "8999c8cf-5214-4406-90c3-9b8e171103c6",
"title": "West Pharmaceutical Services (WST) Appoints New Chief Financial Officer",
"description": "West Pharmaceutical Services, Inc. (WST) has announced the appointment of Robert McMahon as the new Senior Vice President and Chief Financial Officer, effecti",
"keywords": "GuruFocus, Article, News, GuruFocus News, WST",
"snippet": "West Pharmaceutical Services, Inc. (WST, Financial) has announced the appointment of Robert McMahon as the new Senior Vice President and Chief Financial Officer...",
"url": "https://www.gurufocus.com/news/3000852/west-pharmaceutical-services-wst-appoints-new-chief-financial-officer",
"image_url": "https://static.gurufocus.com/logos/0C000009N9.png?5",
"language": "en",
"published_at": "2025-07-24T12:30:17.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "OSUR",
"name": "OraSure Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 43.04663,
"sentiment_score": 0.7184,
"highlights": [
{
"highlight": "Additionally, McMahon has been an Indepe[+253 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "A",
"name": "Agilent Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.659103,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "McMahon brings a wealth of experience to[+329 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "A.MX",
"name": "Agilent Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.658585,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "McMahon brings a wealth of experience to[+329 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HOLX.MX",
"name": "Hologic, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 29.094967,
"sentiment_score": 0,
"highlights": [
{
"highlight": "His career also includes a tenure as CFO[+217 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "WST",
"name": "West Pharmaceutical Services, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 105.78503,
"sentiment_score": 0.38414,
"highlights": [
{
"highlight": "<em>West</em> <em>Pharmaceutical</em> <e[+318 characters]",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "McMahon brings a wealth of experience to[+329 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "McMahon is expected to relocate to <em>W[+255 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Should you invest in <em>West</em> <em>P[+335 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "<em>West</em> <em>Pharmaceutical</em> <em>Services</em> (WST) Appoints New Chief Financial Officer",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "JNJ",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 24.977413,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., and various executive financial roles[+161 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0J5Q.L",
"name": "Hologic, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 29.092472,
"sentiment_score": 0,
"highlights": [
{
"highlight": "His career also includes a tenure as CFO[+217 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0HAV.L",
"name": "Agilent Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 37.656963,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "McMahon brings a wealth of experience to[+329 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HOLX",
"name": "Hologic, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 29.090714,
"sentiment_score": 0,
"highlights": [
{
"highlight": "His career also includes a tenure as CFO[+217 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "H1OL34.SA",
"name": "Hologic, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 29.089878,
"sentiment_score": 0,
"highlights": [
{
"highlight": "His career also includes a tenure as CFO[+217 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "A1GI34.SA",
"name": "Agilent Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.655273,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "McMahon brings a wealth of experience to[+329 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DJNJ2.BA",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 24.979288,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., and various executive financial roles[+161 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DJNJ3.BA",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 24.979288,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., and various executive financial roles[+161 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HO1.DE",
"name": "Hologic Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 29.094128,
"sentiment_score": 0,
"highlights": [
{
"highlight": "His career also includes a tenure as CFO[+217 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "c0e917d3-92c4-4a4e-88d8-123b35ae8800",
"title": "West Pharmaceutical Services Inc (WST) Reports Strong Q2 2025 Results and Updates Full-Year Guidance | WST stock news",
"description": "Summary West Pharmaceutical Services Inc (WST) has released its financial results for the second quarter of 2025, reporting a 9.2% increase in net sales to $766",
"keywords": "GuruFocus, Article, News, GuruFocus News, WST",
"snippet": "Summary\n\nWest Pharmaceutical Services Inc (WST, Financial) has released its financial results for the second quarter of 2025, reporting a 9.2% increase in net s...",
"url": "https://www.gurufocus.com/news/3000696/west-pharmaceutical-services-inc-wst-reports-strong-q2-2025-results-and-updates-fullyear-guidance-wst-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T12:03:12.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "WST",
"name": "West Pharmaceutical Services, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 128.3844,
"sentiment_score": 0.57818,
"highlights": [
{
"highlight": "Summary\n\n<em>West</em> <em>Pharmaceutica[+214 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\n<em>West<[+308 characters]",
"sentiment": 0.9413,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\n<em[+222 characters]",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "Frequently Asked Questions (FAQ)\n\nQ: Wha[+324 characters]",
"sentiment": 0.3939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>West</em> <em>Pharmaceutical</em> <em>Services</em> <em>Inc</em> (WST) Reports Strong Q2 2025 Results and Updates Full-Year Guidance | WST stock news",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "93a3b7fa-440c-40ff-80d5-be7fd7493803",
"title": "WST Surpasses Q2 Revenue Expectations Amid Strong Product Growth | WST Stock News",
"description": "West Pharmaceutical Services, Inc. (WST) reported its second-quarter revenue at $766.5 million, surpassing the consensus estimate of $726.18 million. The compan",
"keywords": "GuruFocus, Article, News, GuruFocus News, WST",
"snippet": "West Pharmaceutical Services, Inc. (WST, Financial) reported its second-quarter revenue at $766.5 million, surpassing the consensus estimate of $726.18 million....",
"url": "https://www.gurufocus.com/news/3000462/wst-surpasses-q2-revenue-expectations-amid-strong-product-growth-wst-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000009N9.png?20",
"language": "en",
"published_at": "2025-07-24T11:34:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "WST",
"name": "West Pharmaceutical Services, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.749054,
"sentiment_score": 0.4037,
"highlights": [
{
"highlight": "<em>West</em> <em>Pharmaceutical</em> <e[+156 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Due to these positive results and advant[+203 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "b3b62f03-18dc-470a-bcad-7b9988d6b77b",
"title": "Twist Bioscience Corp (TWST) Announces Equity Awards to New Employees | TWST stock news",
"description": "Summary Twist Bioscience Corp (TWST), a prominent player in the life sciences sector, announced on [date of press release] the granting of 70,254 equity awards",
"keywords": "GuruFocus, Article, News, GuruFocus News, TWST",
"snippet": "Summary\n\nTwist Bioscience Corp (TWST, Financial), a prominent player in the life sciences sector, announced on [date of press release] the granting of 70,254 eq...",
"url": "https://www.gurufocus.com/news/3002332/twist-bioscience-corp-twst-announces-equity-awards-to-new-employees-twst-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T15:17:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TWST",
"name": "Twist Bioscience Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 63.830036,
"sentiment_score": 0.749625,
"highlights": [
{
"highlight": "Summary\n\n<em>Twist</em> <em>Bioscience</[+278 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Aspects\n\n<em>Twist</em> <em>Bio[+315 characters]",
"sentiment": 0.9698,
"highlighted_in": "main_text"
},
{
"highlight": "Frequently Asked Questions (FAQ)\n\nWhat i[+326 characters]",
"sentiment": 0.9575,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Twist</em> <em>Bioscience</em> Corp (TWST) Announces Equity Awards to New Employees | TWST stock news",
"sentiment": 0.4588,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "51b1d517-b060-45b0-a661-79f636c7dbd7",
"title": "Champions Oncology (CSBR) Trading Resumes After Brief Halt | CSBR Stock News",
"description": "Champions Oncology, Inc. (CSBR) has resumed trading following a temporary suspension. Investors now have the opportunity to engage with the stock once more as m",
"keywords": "GuruFocus, Article, News, GuruFocus News, CSBR",
"snippet": "Champions Oncology, Inc. (CSBR, Financial) has resumed trading following a temporary suspension. Investors now have the opportunity to engage with the stock onc...",
"url": "https://www.gurufocus.com/news/3002298/champions-oncology-csbr-trading-resumes-after-brief-halt-csbr-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T15:15:25.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CSBR",
"name": "Champions Oncology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 80.7094,
"sentiment_score": 0.39385,
"highlights": [
{
"highlight": "<em>Champions</em> <em>Oncology</em>, <e[+184 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+286 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+259 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+232 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Champions</em> <em>[+226 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Champions</em> <em>Oncology</em> <em[+329 characters]",
"sentiment": 0.8885,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Champions</em> <em>Oncology</em> (CSBR) Trading Resumes After Brief Halt | CSBR Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "17381c3f-50a8-4e14-b910-c5383b40008a",
"title": "CSBR Trading Paused Due to Market Volatility | CSBR Stock News",
"description": "Champions Oncology (CSBR) experienced a temporary halt in trading due to heightened market volatility. This pause allows the market to stabilize and prevent ext",
"keywords": "GuruFocus, Article, News, GuruFocus News, CSBR",
"snippet": "Champions Oncology (CSBR, Financial) experienced a temporary halt in trading due to heightened market volatility. This pause allows the market to stabilize and ...",
"url": "https://www.gurufocus.com/news/3002101/csbr-trading-paused-due-to-market-volatility-csbr-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-24T14:47:21.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CSBR",
"name": "Champions Oncology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.195724,
"sentiment_score": 0.362814,
"highlights": [
{
"highlight": "<em>Champions</em> <em>Oncology</em> (CS[+272 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+286 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+256 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+232 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Champions</em> <em>[+226 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Champions</em> <em>Oncology</em> <em[+329 characters]",
"sentiment": 0.8885,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "baf8f778-0db6-4b6d-b930-d98743f11808",
"title": "Champions Oncology Inc (CSBR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Market Challenges",
"description": "Release Date: July 23, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Champions Oncolo",
"keywords": "GuruFocus, Article, News, GuruFocus News, CSBR",
"snippet": "Release Date: July 23, 2025\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nPositive Points\n\nChampions On...",
"url": "https://www.gurufocus.com/news/3000181/champions-oncology-inc-csbr-q4-2025-earnings-call-highlights-record-revenue-and-strategic-growth-amid-market-challenges",
"image_url": "https://static.gurufocus.com/logos/0C00000EK4.png?5",
"language": "en",
"published_at": "2025-07-24T07:11:58.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CSBR",
"name": "Champions Oncology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 98.441925,
"sentiment_score": 0.717133,
"highlights": [
{
"highlight": "Positive Points\n\n<em>Champions</em> <em>[+226 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Champions</em> <em>Oncology</em> <em[+329 characters]",
"sentiment": 0.8885,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Champions</em> <em>Oncology</em> <em>Inc</em> (CSBR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Market Challenges",
"sentiment": 0.4404,
"highlighted_in": "title"
}
]
}
]
}
]
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "Healthcare",
"total_documents": 759,
"sentiment_avg": 0.27914272797458456
}
]
}
Other details
Entity count
- 11,338